Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences – February 01, 2007
Source: PubMed
Summary
Detecting designer drugs like 2C-B is challenging as they metabolize quickly. Researchers developed a method to reliably identify 2C-B use by pinpointing its unique breakdown products in urine. Using advanced gas chromatography-mass spectrometry, they successfully identified specific metabolites in rat urine, even after a common dose. This effective technique promises robust detection of 2C-B intake in humans, offering a vital tool for toxicology.
Abstract
The phenethylamine-derived designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) is known to be extensively metabolized in various species including humans. In rat urine, 2C-B was found to be excreted mainly via its metabolites. In the current study, the toxicological detection of these metabolites in the authors' systematic toxicological analysis (STA) procedure was examined. The STA procedure using full-scan GC-MS allowed proving an intake of a common drug abusers' dose of 2C-B by detection of the O-demethyl deaminohydroxy and two isomers of the O-demethyl metabolites in rat urine. Assuming similar metabolism, the described STA procedure should be suitable for proof of an intake of 2C-B in human urine.